Jim Kastenmayer

Jim Kastenmayer

General Counsel at ARRIVENT BIOPHARMA, INC.

Net worth: 256 590 $ as of 2026-06-29

54 year
Health Technology
Consumer Services

Profile

James Kastenmayer currently works at Arrivent BioPharma, Inc., as Secretary & General Counsel.
Dr. Kastenmayer also formerly worked at AstraZeneca PLC, as Legal Director & Senior Patent Director from 2012 to 2019, Spyre Therapeutics, Inc., as Secretary & General Counsel from 2022 to 2023, MedImmune LLC, as IP Counsel, and Viela Bio, Inc., as Secretary, General Counsel & Senior Vice President from 2020 to 2021.
Dr. Kastenmayer received his doctorate degree from Michigan State University, undergraduate degree from the University of Virginia, and graduate degree from Georgetown University Law Center.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2026-02-01 7,386 ( 0.02% ) 256 590 $ 2026-06-29

Jim Kastenmayer active positions

CompaniesPositionStart
ARRIVENT BIOPHARMA, INC. General Counsel 2023-08-31

Former positions of Jim Kastenmayer

CompaniesPositionEnd
SPYRE THERAPEUTICS, INC. Chief Executive Officer 2022-11-28
VIELA BIO, INC. General Counsel 2021-02-28
ASTRAZENECA PLC General Counsel 2019-11-30
Corporate Officer/Principal -
See the detail of Jim Kastenmayer's experience

Training of Jim Kastenmayer

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

53

1st degree connections

8

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies8

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Consumer Services

Health Technology

Health Technology

  1. Stock Market
  2. Insiders
  3. Jim Kastenmayer